Generic drug manufacturers move to dismiss Walmart's US antitrust claims

( September 3, 2025, 19:47 GMT | Official Statement) -- MLex Summary: Generic drug manufacturers including Teva Pharmaceuticals, Actavis Pharma, Pfizer, Mayne Pharma and over 40 others filed a motion to dismiss Walmart's US antitrust claims over an alleged "fair-share" scheme that fueled price increases for hundreds of generics through an industry-wide strategy to allocate customers and markets based on an agreed-upon code. Walmart's claims come 16 years after the formation of the supposed conspiracies, more than 10 years after public reporting brought to light allegations of collusion and government investigations into the generic drug industry, nine years after other private plaintiffs brought their own allegations, and more than eight after state attorneys general filed their own complaints, rendering its claims time-barred, the defendants said in the filing to the US Eastern District of Pennsylvania. Further, Walmart's invoking of fraudulent concealment, statutory tolling, and its status as a putative member of a Direct Purchaser class in a related action also fail, the plaintiffs' motion said.See attached document: ...